Chaopeng Tang

469 total citations
16 papers, 370 citations indexed

About

Chaopeng Tang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Chaopeng Tang has authored 16 papers receiving a total of 370 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Surgery. Recurrent topics in Chaopeng Tang's work include Renal cell carcinoma treatment (6 papers), Renal and related cancers (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Chaopeng Tang is often cited by papers focused on Renal cell carcinoma treatment (6 papers), Renal and related cancers (5 papers) and Bladder and Urothelial Cancer Treatments (4 papers). Chaopeng Tang collaborates with scholars based in China. Chaopeng Tang's co-authors include Xiaoming Yi, Wenquan Zhou, Jingping Ge, Haowei He, Song Xu, Zhengyu Zhang, Dong Wang, Nana Wang, Zhengyu Zhang and Dian Fu and has published in prestigious journals such as PLoS ONE, Oncotarget and Biomedicine & Pharmacotherapy.

In The Last Decade

Chaopeng Tang

15 papers receiving 367 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chaopeng Tang China 10 280 260 80 48 21 16 370
Haitao Yu China 12 292 1.0× 220 0.8× 103 1.3× 44 0.9× 15 0.7× 28 392
Nihong Lu China 7 252 0.9× 197 0.8× 108 1.4× 50 1.0× 39 1.9× 18 364
Meng‐Die Cheng China 10 154 0.6× 127 0.5× 88 1.1× 35 0.7× 19 0.9× 26 310
Haiqing He China 11 253 0.9× 161 0.6× 102 1.3× 46 1.0× 46 2.2× 20 359
Zequn Niu China 13 227 0.8× 163 0.6× 42 0.5× 50 1.0× 41 2.0× 24 335
Youguang Huang China 10 230 0.8× 132 0.5× 86 1.1× 38 0.8× 26 1.2× 20 353
Zihan Yi China 10 202 0.7× 141 0.5× 54 0.7× 29 0.6× 22 1.0× 17 297
Dongyi Zhu China 9 338 1.2× 332 1.3× 104 1.3× 32 0.7× 45 2.1× 18 507
Yali Min China 5 248 0.9× 143 0.6× 54 0.7× 47 1.0× 21 1.0× 5 348
Xiaowen Kang China 8 154 0.6× 88 0.3× 114 1.4× 47 1.0× 13 0.6× 10 304

Countries citing papers authored by Chaopeng Tang

Since Specialization
Citations

This map shows the geographic impact of Chaopeng Tang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chaopeng Tang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chaopeng Tang more than expected).

Fields of papers citing papers by Chaopeng Tang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chaopeng Tang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chaopeng Tang. The network helps show where Chaopeng Tang may publish in the future.

Co-authorship network of co-authors of Chaopeng Tang

This figure shows the co-authorship network connecting the top 25 collaborators of Chaopeng Tang. A scholar is included among the top collaborators of Chaopeng Tang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chaopeng Tang. Chaopeng Tang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Tang, Chaopeng, Jie Dong, Ping Li, et al.. (2023). Collecting Duct Carcinoma of the Kidney: A Single-Center Retrospective Study of 23 Cases. Technology in Cancer Research & Treatment. 22. 2223907029–2223907029. 4 indexed citations
2.
Zhou, Yulin, Chaopeng Tang, Jie Dong, et al.. (2023). Establishment and validation of a nomogram to select patients with metastatic sarcomatoid renal cell carcinoma suitable for cytoreductive radical nephrectomy. Frontiers in Oncology. 13. 1239405–1239405. 1 indexed citations
3.
Li, Ping, et al.. (2023). Cardamonin suppresses glycolysis and induces oxidative stress by inhibiting PI3K/AKT/mTOR pathway in bladder cancer cells. Tropical Journal of Pharmaceutical Research. 22(8). 1541–1546. 1 indexed citations
4.
Shen, Tianyi, Yulin Zhou, Xiaoming Yi, et al.. (2022). Exosomal AP000439.2 from clear cell renal cell carcinoma induces M2 macrophage polarization to promote tumor progression through activation of STAT3. Cell Communication and Signaling. 20(1). 152–152. 35 indexed citations
5.
Zhong, Jing, Xiumin Zhou, Zhifeng Wei, et al.. (2022). Mucinous Tubular and Spindle Cell Carcinoma of the Kidney: A Study of Clinical, Imaging Features and Treatment Outcomes. Frontiers in Oncology. 12. 865263–865263. 9 indexed citations
6.
Tang, Chaopeng, et al.. (2021). Incidence, Clinical Characteristics, and Survival of Collecting Duct Carcinoma of the Kidney: A Population-Based Study. Frontiers in Oncology. 11. 727222–727222. 12 indexed citations
7.
Du‌, Bowen, Yulin Zhou, Xiaoming Yi, et al.. (2020). Identification of Immune-Related Cells and Genes in Tumor Microenvironment of Clear Cell Renal Cell Carcinoma. Frontiers in Oncology. 10. 1770–1770. 8 indexed citations
8.
Xu, Zhenyu, Ding Wu, Dian Fu, et al.. (2020). Nobiletin inhibits viability of human renal carcinoma cells via the JAK2/STAT3 and PI3K/Akt pathway. Cellular and Molecular Biology. 66(5). 199–203. 11 indexed citations
9.
Shen, Tianyi, Xiaoming Yi, Zhengyu Zhang, et al.. (2018). Crosstalk between long non‐coding RNAs and Wnt/β‐catenin signalling in cancer. Journal of Cellular and Molecular Medicine. 22(4). 2062–2070. 38 indexed citations
10.
Fu, Dian, Jie Dong, Ping Li, et al.. (2017). MiRNA-21 has effects to protect kidney injury induced by sepsis. Biomedicine & Pharmacotherapy. 94. 1138–1144. 32 indexed citations
11.
He, Haowei, Nana Wang, Xiaoming Yi, Chaopeng Tang, & Dong Wang. (2017). Long non-coding RNA H19 regulates E2F1 expression by competitively sponging endogenous miR-29a-3p in clear cell renal cell carcinoma. Cell & Bioscience. 7(1). 65–65. 62 indexed citations
12.
Fu, Dian, Ping Li, Wen Cheng, et al.. (2017). Impact of vascular endothelial growth factor gene-gene and gene-smoking interaction and haplotype combination on bladder cancer risk in Chinese population. Oncotarget. 8(14). 22927–22935. 17 indexed citations
13.
Xu, Song, Xiaoming Yi, Chaopeng Tang, et al.. (2016). Long non-coding RNA ATB promotes growth and epithelial-mesenchymal transition and predicts poor prognosis in human prostate carcinoma. Oncology Reports. 36(1). 10–22. 82 indexed citations
14.
He, Haowei, Linhui Wang, Wenquan Zhou, et al.. (2015). MicroRNA Expression Profiling in Clear Cell Renal Cell Carcinoma: Identification and Functional Validation of Key miRNAs. PLoS ONE. 10(5). e0125672–e0125672. 51 indexed citations
15.
Tang, Chaopeng, Zhenyu Xu, Xiaoming Yi, et al.. (2015). Fast track surgery vs. conventional management in the perioperative care of retroperitoneal laparoscopic adrenalectomy.. PubMed. 8(9). 16207–14. 7 indexed citations
16.
Xu, Zhenyu, Zhengyu Zhang, Jianping Gao, et al.. (2014). A modified adrenal gland-sparing surgery based on retroperitoneal laparoscopic radical nephrectomy. World Journal of Surgical Oncology. 12(1). 179–179.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026